SHH and squamous cell lung carcinoma: For instance, overexpression of PEBP4 results in the PI3K/Akt and SHH pathways activation, whereas PEBP4 silencing activates the ERK and MAPKs pathways in lung squamous cell carcinoma (Yu et al., 2020).